18:14:14 EST Tue 17 Nov 2026
Enter Symbol
or Name
USA
CA



Vitalist Inc.
Symbol VITA
Shares Issued 66,763,533
Close 2026-11-17 C$ 0.68
Market Cap C$ 45,399,202
Recent Sedar+ Documents

ORIGINAL: Vitalist Reports Second Quarter 2027 Financial Results

2026-11-17 17:15 ET - News Release

CALGARY, Alberta, Nov. 17, 2026 (GLOBE NEWSWIRE) -- Vitalist Inc. (TSX-V: VITA.V; OTCQB: VTLSF) (“Vitalist”, “we”, “our”, or the “Company”), a wearable operating-system focused technology company, today announced its financial results for the six months ended September 30, 2026 (“Q2 2027”). The related financial statements and accompanying notes, and Management’s Discussion and Analysis for Q2 2027 (“MD&A”) are available on SEDAR+ at www.sedarplus.ca and on the Vitalist’s website at www.vitalist.co.

All dollar amounts in this press release are expressed in the Canadian dollars.

Q22027 Highlights

  • Revenue in the three month period ended September 30, 2026 decreased by $1.77 million reflecting a decrease of 92% compared to the corresponding period of the prior year. Revenue decreased by $2.50 million reflecting a decrease of 73% in the six month period ended September 30, 2026 as compared to the corresponding period of the prior year. The decrease is related to lower sales velocity at retail and distributors not needing to replenish inventory given their current stock. This was partially offset by the unwinding of previously estimated B2B refund and sales inducement provisions.
  • The gross profit margin in the three month period ended September 30, 2026 was negligible, as compared to 40% in the corresponding period of the prior year, a decrease of $0.78 million. The decrease was due to relatively higher refund provision adjustments than in the comparable period. The gross profit margin for the six month period ended September 30, 2026 increased to 48% as compared to 36% for the corresponding period of the prior year. The increase is due to improved product margin economics and the partial unwinding of refund, warranty and sales inducement provisions on sales.
  • The Company incurred a net loss of $2.45 million and $3.56 million for the three and six months ended September 30, 2026 respectively. In the prior year the Company had recorded a net income of $0.15 million and a net loss of $0.31 million for the six months ended September 30, 2025, respectively. The increase in net loss was primarily driven by a decrease in revenue, coupled with an increase in operating expenses related to the acquisition of Somatix, Inc.
  • Operating cash outflows were approximately $5.60 million for the six month ended September 30, 2026, compared with approximately $2.44 million in the six month period ended September 30, 2025. The increase was attributable to a temporary increase to operating expenditures from the newly acquired Somatix entity, one time transaction costs and decreased revenue.

Outlook

Looking forward, Vitalist Inc. remains focused on building its presence across the consumer and enterprise health markets. The Company is continuing to execute on its exclusive five-year brand partnership with Reebok, beginning with the November 2026 launch of the Reebok Kinetic smartwatch. Running on Vitalist’s proprietary operating system, VitalOS™, the release will demonstrate the platform’s core functionality, up to 7-day battery life, and hardware compatibility, providing a commercial use case to support potential future software licensing discussions. Concurrently, following the acquisition of remote patient monitoring business Somatix, Inc., Vitalist is working to broaden its portfolio into the medical wearables segment. By integrating Somatix’s technology into VitalOS™, the Company intends to develop recurring revenue opportunities across enterprise healthcare and consumer channels over time.

"As we move through the fiscal year, our focus has been on broadening both our physical and digital distribution footprint," said Kalvie Legat, CEO of Vitalist. "We have added placement across several regional and national retail formats, including travel centers, specialty storefronts, and off-price outlets. Alongside our engagement with Pattern Inc. to support our e-commerce operations across major online marketplaces, these channels are intended to provide a wider distribution base for upcoming quarters.”

Selected Financial Information

  Three months endedSix months ended
  September 30,September 30,
  2026(2)2025(1)2026
2025(1)
  (revised)(revised) (revised)
  $$$$
Total revenue
164,624 1,937,930921,430 3,417,812 
Gross profit
511 779,905441,945 1,236,752 
Net loss
(2,453,422)152,196(3,562,494)(312,332)
Net cash used in operating activities
(2,490,263)119,729(5,595,316)(2,444,139)
Basic & diluted loss per share
(0.04)0.00(0.06)(0.01)
(1)Comparative figures for the three and six months ended September 30, 2025 have been revised to reflect the correction of prior-period revenue and cost of products misstatements. Refer to "Correction of Prior-Period Misstatements" under the "BASIS OF PRESENTATION" section and Note 2(c) of the Q2 FY27 Financial Statements.
(2)Comparative figures for the prior quarter ended June 30, 2026, have been revised to reflect the correction of prior-period gains and accretion. Refer to "Correction of Prior-Period Misstatements" under the "BASIS OF PRESENTATION" section and Note 2(d) of the Q2 FY27 Financial Statements.


As atSeptember 30,
2026
March 31,
2026
 $$
Total assets10,582,0521,039,063
Total non-current financial liabilities11,369,5936,645,271
   

About Vitalist Inc.

Vitalist Inc. is an innovative technology provider that helps brands build better products. Through VitalOS™, brands create seamlessly connected devices and applications that adapt to each user. By uniting hardware and software with intelligent analytics, we're building an ecosystem of personalized solutions that enhance human potential.

▷ For more information visit: www.vitalist.co | Investor Materials | LinkedIn

▷ Join the Vitalist distribution list: www.vitalist.co/investors

Investor Relations Contact

For further information about Vitalist Inc. please contact:

Kalvie Legat, CEO
Vitalist
+1 (403) 560-9635
ir@vitalist.ca

Walter Frank
IMS Investor Relations
+1 (203) 972-9200
vitalist@imsinvestorrelations.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release

Forward-Looking Information

This press release contains “forward-looking information” within the meaning of applicable Canadian securities laws. In general, forward-looking information is disclosure about future conditions, courses of action, and events, including information about prospective financial performance or financial position. The use of any of the words “anticipates”, “believes”, “expects”, “intends”, “plans”, “will”, “would”, and similar expressions are intended to identify forward-looking information. Forward-looking statements included or incorporated by reference in this press release include, without limitation, with respect to:

  • the ability of the Company to continue as a going concern;
  • the impact on the Company of the voluntary assignment into bankruptcy of eBuyNow eCommerce Ltd. (“EBN”), a wholly-owned Canadian subsidiary of the Company, which was filed by EBN on June 27, 2023 pursuant to the Bankruptcy and Insolvency Act (R.S.C., 1985, c. B-3) (the “Act”) (collectively, the “Bankruptcy”);
  • the commercial success of, and reliance upon, the five-year brand licensing agreement with Reebok as the Company's primary consumer hardware vehicle;
  • the impact on the Company of the acquisition of Somatix, Inc. (“Somatix”);
  • the effects of global supply constraints on the Company and the likelihood that such constraints will continue to occur and impact the Company;
  • the plans of the Company for the Reebok (defined below) product category, the status of the Reebok product category relative to those plans, and the anticipated timing and costs to advance the Reebok product category;
  • the plans of the Company for the Vitalist (defined below) product category, the status of the Vitalist product category relative to those plans, and the anticipated timing and costs to advance the Vitalist product category;
  • the plans of the Company to terminate certain product lines and product categories;
  • the strategies of the Company for customer retention and growth;
  • anticipated demand for the products and services of the Company, and its ability to meet that demand;
  • the Company’s intent to maintain a flexible capital structure;
  • the ability of the Company to generate sufficient cash to maintain its capacity and fund its growth and development;
  • fluctuations in the liquidity of the Company;
  • the ability of the Company to meet its obligations as they become due;
  • the plans of the Company for remedying its working capital deficiency;
  • the need for the Company to pursue additional sources of financing and the ability of the Company to obtain such additional sources of financing;
  • capital expenditures not yet committed, but required, to maintain the capacity of the Company and fund its growth and development;
  • fluctuations in the capital resources of the Company;
  • the sources of financing that the Company has arranged, but not yet used; and
  • the plans of the Company to reduce general and administrative expenses.

The forward-looking information is based on certain key expectations and assumptions, including the continuance of manufacturing operations at the Company’s partner factories in Asia, the timing of product launches, shipments and deliveries, forecast sales price and sales volumes of the Company’s products and the ability of the Company to secure additional sources of financing in the future.

There can be no assurance that the Company will be able to secure additional financing in the future in a timely manner or at all. If the Company fails to secure additional financing, the Company may have insufficient liquidity and capital resources to operate its business resulting in material uncertainty regarding the Company’s ability to meet its financial obligations as they become due and continue as a going concern.

Although the Company believes that the expectations and assumptions on which such forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company cannot give any assurance that it will prove to be accurate. By its nature, forward-looking information is subject to various risks, which could cause the actual results and expectations to differ materially from the anticipated results or expectations expressed in this MD&A. Such risks and uncertainties include, without limitation:

  • there is the potential for litigation to arise from creditors in connection with the Bankruptcy resulting in contingent liabilities and additional legal costs to the Company;
  • certain liabilities of EBN and its subsidiaries may not be extinguished in connection with the Bankruptcy;
  • the Company may fail to obtain, maintain, or comply with required medical device regulatory approvals, clearances, or clinical standards for its remote patient monitoring solutions;
  • the Company faces enhanced compliance burdens, penalties, and litigation risks associated with handling Protected Health Information and stringent health data privacy regulations;
  • the Company's near-term consumer hardware revenues are concentrated within a single brand license with Reebok;
  • the Company's reported revenue and gross margins are subject to volatility from retail channel sell-through trends, return provisions, price protections, and variable consideration adjustments;
  • the Company is at risk to possible hidden or contingent liabilities, including pending litigation, regulatory non-compliance, or cybersecurity vulnerabilities incurred by its recent acquisition of Somatix;
  • in connection with the Somatix acquisition, a substantial amount of goodwill and intangible assets will likely be recognized and is at risk of impairment;
  • the Company may require additional funds by way of debt or equity financings to continue to fund its operating, investing, and financing activities;
  • the Company may continue to experience negative impacts of global supply constraints;
  • the Company has limited financial resources, a working capital deficiency and a history of negative cash flow, including negative cash flow from operating activities, and may require additional funds by way of debt or equity financings to continue to fund its operating, investing, and financing activities;
  • the Company is at risk of not being able to settle its debt obligations or to extend, replace, or refinance its existing debt obligations on terms reasonably acceptable to the Company, or at all;
  • global operations risks including unexpected changes in foreign governmental laws, policies, regulations or project locations concerning the import and export of goods, services and technology, and exposure to global credit and financial factors on consumers in the Company’s areas of operations;
  • the Company cannot guarantee that it will become cash-flow positive or profitable, and negative cash flow or the failure to become profitable in any future fiscal period could result in an adverse material change to the Company;
  • the Company relies on third party manufacturing and from time to time there may be product defects caused by the manufacturing process, assembly, or engineering, particularly when first introduced or when new versions are released
  • global manufacturing risks including the risk that products manufactured by the Company may be subject to changing tariffs applied by selling countries to countries of origin with little or no warning due to the Company’s use of factories in China, Vietnam, Taiwan, or Malaysia, from time to time;
  • the Company’s revenues may vary over time and with seasonality;
  • the Company may not generate sufficient revenue to sustain operations;
  • the Company may not be able to successfully negotiate contracts to source, develop, manufacture, pack, ship, distribute, or sell products economically, if at all;
  • the Company relies on major components to be manufactured on an original equipment manufacturer basis, which involves several risks, including the possibility of defective products, a shortage of components, delays in delivery schedules, and increases in component costs;
  • demand for international sales may not grow as expected or at all, and there is no assurance that the Company will succeed in expanding into new markets;
  • the ability of the Company to successfully enter new markets is subject to uncertainties;
  • there can be no assurance that the business and growth strategy of the Company will enable the Company to be profitable;
  • the Company relies on licenses from third parties, and there can be no assurance that these third-party licenses will continue to be available to the Company on commercially reasonable terms, or at all;
  • the Company may be required to obtain and maintain certain permits, licenses, and approvals in the jurisdictions where its products or technologies are being commercialized or sold, and there can be no assurances that the Company will be able to obtain or maintain any such necessary licenses, permits, or approvals;
  • the future growth and profitability of the Company may be dependent in part on the effectiveness and efficiency of its sales and marketing expenditures;
  • the Company may be exposed to product liability claims in the use of its products;
  • the market for the Company’s products is characterized by rapidly changing technology, evolving industry standards, and customer requirements, which may cause the introduction of products embodying new technology and the emergence of new industry standards to render the existing technology solutions of the Company obsolete or unmarketable, and may also exert price pressures on the Company’s existing solutions;
  • the Company may not be able to develop new market relevant products in a timely manner;
  • the ability of the Company to generate revenue will largely depend upon the effectiveness of its sales and marketing efforts, both domestically and internationally;
  • the success of the Company is largely dependent on the performance of its key directors, officers, and employees;
  • the commercial success of the Company is reliant on the ability to develop new or improved technologies, manufacture products, and to successfully obtain patents or other proprietary or statutory protection for these technologies and products in Canada and other jurisdictions;
  • the Company could become subject to a wide variety of cyberattacks on its networks and systems;
  • the Company is engaged in an industry that is highly competitive and rapidly evolving;
  • the new products provided by the competitors of the Company may render the existing products of the Company less competitive;
  • the Company uses contract manufacturers to manufacture its products and products under development and its reliance on contract manufacturers subjects it to significant operational risks, many of which would impair its ability to deliver products to its customers should they occur;
  • the Company may become party to litigation, mediation, or arbitration from time to time in the ordinary course of business;
  • any future acquisitions may result in significant transaction expenses and may present additional risks associated with entering new markets, offering new products, and integrating the acquired companies;
  • the business plan of the Company anticipates rapid growth, and the Company may not be able to continue to attract, hire, and retain the highly skilled and motivated officers and employees necessary to manage its growth effectively;
  • the computer infrastructure of the Company may potentially be vulnerable to physical or electronic computer break-ins, viruses, and similar disruptive problems and security breaches;
  • the Company may not be able to enhance its current products or develop new products at competitive prices or in a timely manner;
  • the Company is subject to taxes in Canada and other foreign jurisdictions, and in the ordinary course of business, there may be many transactions and calculations where the ultimate tax determination is uncertain;
  • a customer of the Company or counterparty to a financial instrument of the Company may fail to meet its contractual obligations to the Company;
  • the ability of the Company to manage growth effectively will require it to continue to implement and improve its operational and financial systems, which may not always be possible;
  • the forecasts and models of the Company could be inaccurate;
  • the accounting estimates and judgments of the Company could be incorrect;
  • the Company may fail to develop or maintain effective controls over financial reporting;
  • there is no assurance that insurance will be consistently available to the Company on economic terms, if at all; and
  • the risk factors included in the Company’s other continuous disclosure documents available on SEDAR+ at www.sedarplus.ca.

Readers are cautioned not to place undue reliance on this forward-looking information, which is given as of the date of this press release, and to not use such forward-looking information other than for its intended purpose. Vitalist undertakes no obligation to update publicly or revise any forward-looking information, whether as a result of new information, future events, or otherwise, except as required by applicable securities law.


Primary Logo

© 2026 Canjex Publishing Ltd. All rights reserved.